Morgan Stanley Maintains Evelo Biosciences (EVLO) Equal-Weight Recommendation
Fintel reports that on July 26, 2023, Morgan Stanley maintained coverage of Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight recommendation.
Symbol | Last Price | Change | % Change |
---|---|---|---|